drugset / Trial / NCT01001429
Dexmedetomidine Versus Propofol in Vitreoretinal Surgery
RandomizedParallel-groupTriple-blindTreatment
Summary
The investigators would like to determine if using Dexmedetomidine alone or in a reduced dose can prevent or reduce the incidence of adverse effects, while providing adequate sedation, and respiratory stability as compared to propofol.
Timeline
- Start
- 2009-10
- Primary completion
- 2013-03
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.2 ug/kg | Intravenous |
| Subject | Dexmedetomidine | Other / unclassified | 0.7 ug/kg | Intravenous |
| Comparator | Propofol | Small molecule | 25 ug/kg | Intravenous |
| Comparator | Propofol | Small molecule | 100 ug/kg | Intravenous |